Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Coho who wrote (916)	5/9/1998 6:30:00 PM
From: Hippieslayer	Read Replies (1) \| Respond to of 1501

I have no idea who this new CEO is, but by the heavy weights that occpy the BOD, I would have thought that they would have lured someone with more name and industry recognition. That's not to say that this new CEO isn't qualified, cuz he probably is, but his resume is not what I had expected. there might be some truth to what you have written in regards to "things starting to happen" for IZYPF in term's major deals. It still remains unclear whether stockholders will benefit or not. Re Salari: He should have just stuck to the science and gotten a seasoned pharm. insider to run the company long ago.